HCA Holdings, Inc. (NYSE:HCA)‘s stock had its “buy” rating reiterated by investment analysts at KeyCorp in a research note issued on Thursday. They presently have a $95.00 target price on the stock. KeyCorp’s price target would indicate a potential upside of 23.30% from the stock’s current price.

Several other equities analysts also recently commented on HCA. Argus initiated coverage on shares of HCA Holdings in a research note on Wednesday, June 28th. They set a “buy” rating and a $100.00 price objective for the company. BidaskClub downgraded shares of HCA Holdings from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Bank of America Corporation downgraded shares of HCA Holdings from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $102.00 to $92.00 in a research note on Wednesday, July 26th. Morgan Stanley initiated coverage on shares of HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price objective for the company. Finally, Zacks Investment Research downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research note on Friday, July 14th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $92.88.

Shares of HCA Holdings (NYSE HCA) traded up 0.89% during mid-day trading on Thursday, reaching $77.05. The company’s stock had a trading volume of 1,922,216 shares. HCA Holdings has a 12 month low of $67.00 and a 12 month high of $91.03. The company’s 50-day moving average is $79.46 and its 200 day moving average is $83.83. The firm has a market cap of $27.83 billion, a price-to-earnings ratio of 10.33 and a beta of 0.67.

HCA Holdings (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.80 by $0.05. The business had revenue of $10.73 billion during the quarter, compared to the consensus estimate of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.66 earnings per share. On average, equities analysts anticipate that HCA Holdings will post $7.19 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/08/hca-holdings-inc-hca-given-buy-rating-at-keycorp.html.

In other HCA Holdings news, insider Jonathan B. Perlin sold 71,063 shares of the company’s stock in a transaction dated Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $84.86, for a total transaction of $182,449.00. The disclosure for this sale can be found here. Insiders have sold 77,513 shares of company stock worth $6,651,455 in the last quarter. 2.90% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. grew its holdings in HCA Holdings by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after purchasing an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. grew its holdings in HCA Holdings by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after purchasing an additional 320 shares during the period. Atlantic Trust LLC purchased a new stake in HCA Holdings in the second quarter worth about $118,000. Lee Financial Co purchased a new stake in HCA Holdings in the second quarter worth about $125,000. Finally, Acrospire Investment Management LLC grew its holdings in HCA Holdings by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after purchasing an additional 200 shares during the period. Institutional investors and hedge funds own 73.77% of the company’s stock.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.